|
As Torrent is actively engaged in advanced pre-clinical studies leading to Phase-I clinical trials and eventual proof of concept in man, we are open to exploring partnership opportunities for following two programs.
| » |
AGE Breaker |
| |
AGE (Advanced Glycosylation End-products) breaker compound in advanced pre-clinical stage have potential in correcting diabetic complications like neuropathy, nephropathy, retinopathy and heart failure. |
We are constantly and proactively seeking human health opportunities for New Chemical Entities (NCE's) as product candidates for development, where there are unmet medical needs and where new or better treatments are needed. Early research collaborations potentially leading to an NCE as well as platform research technologies and research tools are also part of our collaboration strategy.
Our major research areas including the following:
- Metabolic Disorders
- Cardiovascular Disorders
- Cerebrovascular Disorders
We look for strategic alliances that facilitate the discovery, development and commercialization of novel products complementing our areas of focus that mutually benefit Torrent and our collaborators.
Contact for business queries:
Dr. Chaitanya Dutt
Director, Research and Development
Torrent Research Centre
P.O. BHAT
Dist; GANDHINAGAR
GUJARAT
382428 INDIA
Phone No : +91-079-23969107/120
Email : cdutt@torrentpharma.com
|
